Data / Form D filings / Cage Pharmaceuticals, Inc.
Cage Pharmaceuticals, Inc.: Form D filings
Cage Pharmaceuticals, Inc., a health care company in New York, NY, filed 3 Form D notices with the SEC between 2018 and 2024. The latest, on May 31, 2024, reports $137,490 sold of a $137,490 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 512 W. 22nd Street, 5th Floor, New York, NY, 10011
- Phone
- (917) 832-1832
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1727073
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2024 | New notice | $137,490 | $137,490 | 2 | May 1, 2024 | sec.gov | |
| Jul 12, 2019 | New notice | $480,000 | $480,000 | 1 | Jul 10, 2019 | sec.gov | |
| Jan 5, 2018 | New notice | $1,700,000 | $350,000 | $1,350,000 | 1 | Dec 22, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Olagunju | Executive Officer, Director | |
| Brian Malik | Director | |
| Nick Papadopoulos | Director | |
| Isaac Ro | Director |
Other health care companies in New York that filed recently
- MOCEAN HOLDINGS Corp $1.5 million · Oct 27, 2026
- Frictionworx Inc. $40,000 · Oct 13, 2026
- Atmos Clinic, Inc. $6 million · Oct 8, 2026
- PreciseDx, Inc. $3.7 million · Oct 7, 2026
- Amani Therapeutics, Inc. $35 million · Oct 1, 2026
- Click Therapeutics, Inc. $50 million · Oct 1, 2026
Every Form D from the week of May 27, 2024 · All recent filings in New York · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Cage Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.